Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Safety Assessment of Hypofractionated Postoperative Radiotherapy (H-PORT) for Intermediate-Risk Head and Neck Cancer

NCT05540899 is registered in ClinicalTrials.gov with American College of Radiology as lead sponsor.

NCT NCT05540899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05540899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Safety Assessment of Hypofractionated Postoperative Radiotherapy (H-PORT) for Intermediate-Risk Head and Neck Cancer
Lead sponsor
American College of Radiology
Phase
Phase 1
Overall status
Active, not recruiting
Start date
November 8, 2023
Completion date
November 30, 2028
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, head and neck squamous cell carcinoma, squamous cell carcinoma of the larynx, squamous cell carcinoma of the oral cavity, squamous cell carcinoma of the oropharynx